SUMITOMO PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 373 JPY | -6.75% |
|
-8.80% | -19.96% |
| 02/05 | Fed Outlook, Earnings Season Roil Asian Stock Markets | MT |
| 02/05 | Sumitomo Pharma Sees Impairment Losses and Restructuring Expenses in Fiscal 2024 | MT |
ETFs positioned on Sumitomo Pharma Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 15 M€ | +11.75% | ||
| 0.15% | 67,864 M€ | +15.20% | ||
| 0.13% | 31,732 M€ | +15.18% | - | |
| 0.13% | 1,198 M€ | +14.37% | - | |
| 0.11% | 1,120 M€ | +1.09% | ||
| 0.10% | 16,729 M€ | +14.33% | - | |
| 0.06% | 4 M€ | +16.67% | ||
| 0.06% | 60 M€ | +16.25% | ||
| 0.05% | 14 M€ | +18.73% | ||
| 0.05% | 73 M€ | +18.87% | ||
| 0.03% | 5,115 M€ | +16.14% | ||
| 0.03% | 10,207 M€ | +16.36% | ||
| 0.03% | 18 M€ | +16.15% | - | |
| 0.02% | 144,586 M€ | +16.55% | ||
| 0.02% | 20,721 M€ | +15.40% | - | |
| 0.02% | 66,066 M€ | +16.86% | - | |
| 0.01% | 773 M€ | -.--% | - | |
| 0.01% | 7 M€ | +2.57% | - | |
| 0.00% | 31 M€ | +4.25% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +6.29% | - | |
| 0.00% | 389 M€ | +6.29% | - | |
| 0.00% | 39 M€ | +4.22% | - | |
| 0.00% | 302 M€ | +4.05% | - | |
| 0.00% | 34 M€ | +2.04% | - |
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
373
JPY
Average target price
333.8
JPY
Spread / Average Target
-10.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.96% | 1.01B | |
| +29.68% | 699B | |
| +25.07% | 571B | |
| -4.35% | 364B | |
| +17.65% | 326B | |
| +3.77% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.79% | 154B |
- Stock Market
- Equities
- 4506 Stock
- Funds and ETFs Sumitomo Pharma Co., Ltd.
